Table of Contents 1 Market Overview 1.1 Antivenom Introduction 1.2 Market Analysis by Type 1.2.1 Polyvalent antivenom 1.2.2 Monovalent antivenom 1.3 Market Analysis by Applications 1.3.1 Retail Pharmacies 1.3.2 Hospitals 1.3.3 Others 1.4 Market Analysis by Regions 1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey) 1.4.1.1 Germany Market States and Outlook (2012-2022) 1.4.1.2 France Market States and Outlook (2012-2022) 1.4.1.3 UK Market States and Outlook (2012-2022) 1.4.1.4 Italy Market States and Outlook (2012-2022) 1.4.1.5 Russia Market States and Outlook (2012-2022) 1.4.1.6 Turkey Market States and Outlook (2012-2022) 1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran) 1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022) 1.4.2.2 UAE Market States and Outlook (2012-2022) 1.4.2.3 Israel Market States and Outlook (2012-2022) 1.4.2.4 Iran Market States and Outlook (2012-2022) 1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria) 1.4.3.1 South Africa Market States and Outlook (2012-2022) 1.4.3.2 Nigeria Market States and Outlook (2012-2022) 1.4.3.3 Egypt Market States and Outlook (2012-2022) 1.4.3.4 Algeria Market States and Outlook (2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 CSL Behring 2.1.1 Business Overview 2.1.2 Antivenom Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 CSL Behring Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Merck & Co., Inc. 2.2.1 Business Overview 2.2.2 Antivenom Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Merck & Co., Inc. Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 BTG Plc 2.3.1 Business Overview 2.3.2 Antivenom Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 BTG Plc Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Pfizer 2.4.1 Business Overview 2.4.2 Antivenom Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Pfizer Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Haffkine Bio-Pharmaceutical Corporation 2.5.1 Business Overview 2.5.2 Antivenom Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Rare Disease Therapeutics 2.6.1 Business Overview 2.6.2 Antivenom Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Rare Disease Therapeutics Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Flynn Pharma 2.7.1 Business Overview 2.7.2 Antivenom Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 Flynn Pharma Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Vins Bioproducts 2.8.1 Business Overview 2.8.2 Antivenom Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 Vins Bioproducts Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Bharat Serums and Vaccines 2.9.1 Business Overview 2.9.2 Antivenom Type and Applications 2.9.2.1 Type 1 2.9.2.2 Type 2 2.9.3 Bharat Serums and Vaccines Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 Serum Biotech 2.10.1 Business Overview 2.10.2 Antivenom Type and Applications 2.10.2.1 Type 1 2.10.2.2 Type 2 2.10.3 Serum Biotech Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 EMEA Antivenom Market Competition, by Manufacturer 3.1 EMEA Antivenom Sales and Market Share by Manufacturer 3.2 EMEA Antivenom Revenue and Market Share by Manufacturer 3.3 EMEA Antivenom Price by Manufacturer (2016-2017) 3.4 Market Concentration Rate 3.4.1 Top 3 Antivenom Manufacturer Market Share 3.4.2 Top 5 Antivenom Manufacturer Market Share 3.5 Market Competition Trend 4 EMEA Antivenom Market Analysis by Regions 4.1 EMEA Antivenom Sales, Revenue and Market Share by Regions 4.1.1 EMEA Antivenom Sales by Regions (2012-2017) 4.1.2 EMEA Antivenom Revenue by Regions (2012-2017) 4.2 Europe Antivenom Sales and Growth (2012-2017) 4.3 Middle East Antivenom Sales and Growth (2012-2017) 4.4 Africa Antivenom Sales and Growth (2012-2017) 5 Europe Antivenom by Countries, Type, Application and Manufacturers 5.1 Europe Antivenom Sales, Revenue and Market Share by Countries 5.1.1 Europe Antivenom Sales by Countries (2012-2017) 5.1.2 Europe Antivenom Revenue by Countries (2012-2017) 5.1.3 Germany Antivenom Sales and Growth (2012-2017) 5.1.4 France Antivenom Sales and Growth (2012-2017) 5.1.5 UK Antivenom Sales and Growth (2012-2017) 5.1.6 Russia Antivenom Sales and Growth (2012-2017) 5.1.7 Italy Antivenom Sales and Growth (2012-2017) 5.1.8 Turkey Antivenom Sales and Growth (2012-2017) 5.2 Europe Antivenom Sales and Revenue (value) by Manufacturers (2016-2017) 5.2.1 Europe Antivenom Sales by Manufacturers (2016-2017) 5.2.2 Europe Antivenom Revenue by Manufacturers (2016-2017) 5.3 Europe Antivenom Sales by Type (2012-2017) 5.4 Europe Antivenom Sales by Application (2012-2017) 6 Middle East Antivenom by Countries, Type, Application and Manufacturers 6.1 Middle East Antivenom Sales, Revenue and Market Share by Countries 6.1.1 Middle East Antivenom Sales by Countries (2012-2017) 6.1.2 Middle East Antivenom Revenue by Countries (2012-2017) 6.1.3 Saudi Arabia Antivenom Sales and Growth (2012-2017) 6.1.4 Israel Antivenom Sales and Growth (2012-2017) 6.1.5 UAE Antivenom Sales and Growth (2012-2017) 6.1.6 Iran Antivenom Sales and Growth (2012-2017) 6.2 Middle East Antivenom Sales and Revenue (value) by Manufacturers (2016-2017) 6.2.1 Middle East Antivenom Sales by Manufacturers (2016-2017) 6.2.2 Middle East Antivenom Revenue by Manufacturers (2016-2017) 6.3 Middle East Antivenom Sales by Type (2012-2017) 6.4 Middle East Antivenom Sales by Application (2012-2017) 7 Africa Antivenom by Countries, Type, Application and Manufacturers 7.1 Africa Antivenom Sales, Revenue and Market Share by Countries 7.1.1 Africa Antivenom Sales by Countries (2012-2017) 7.1.2 Africa Antivenom Revenue by Countries (2012-2017) 7.1.3 South Africa Antivenom Sales and Growth (2012-2017) 7.1.4 Nigeria Antivenom Sales and Growth (2012-2017) 7.1.5 Egypt Antivenom Sales and Growth (2012-2017) 7.1.6 Algeria Antivenom Sales and Growth (2012-2017) 7.2 Middle East Antivenom Sales and Revenue (value) by Manufacturers (2016-2017) 7.2.1 Middle East Antivenom Sales by Manufacturers (2016-2017) 7.2.2 Middle East Antivenom Revenue by Manufacturers (2016-2017) 7.3 Middle East Antivenom Sales by Type (2012-2017) 7.4 Middle East Antivenom Sales by Application (2012-2017) 8 EMEA Antivenom Market Segment by Type 8.1 EMEA Antivenom Sales, Revenue and Market Share by Type (2012-2017) 8.1.1 EMEA Antivenom Sales and Market Share by Type (2012-2017) 8.1.2 EMEA Antivenom Revenue and Market Share by Type (2012-2017) 8.2 Polyvalent antivenom Sales Growth and Price 10.2.1 EMEA Polyvalent antivenom Sales Growth (2012-2017) 10.2.2 EMEA Polyvalent antivenom Price (2012-2017) 8.3 Monovalent antivenom Sales Growth and Price 10.3.1 EMEA Monovalent antivenom Sales Growth (2012-2017) 10.3.2 EMEA Monovalent antivenom Price (2012-2017) 9 EMEA Antivenom Market Segment by Application 9.1 EMEA Antivenom Sales Market Share by Application (2012-2017) 9.2 Retail Pharmacies Sales Growth (2012-2017) 9.3 Hospitals Sales Growth (2012-2017) 9.4 Others Sales Growth (2012-2017) 10 EMEA Antivenom Market Forecast (2017-2022) 10.1 EMEA Antivenom Sales, Revenue and Growth Rate (2017-2022) 10.2 Antivenom Market Forecast by Regions (2017-2022) 10.2.1 Europe Antivenom Market Forecast by Regions (2017-2022) 10.2.1.1 Germany Antivenom Sales Forecast 2017-2022 10.2.1.2 France Antivenom Sales Forecast 2017-2022 10.2.1.3 UK Antivenom Sales Forecast 2017-2022 10.2.1.4 Russia Antivenom Sales Forecast 2017-2022 10.2.1.5 Italy Antivenom Sales Forecast 2017-2022 10.2.1.6 Turkey Antivenom Sales Forecast 2017-2022 10.2.2 Middle East Market Forecast by Regions (2017-2022) 10.2.2.1 Saudi Arabia Antivenom Sales Forecast 2017-2022 10.2.2.2 Israel Antivenom Sales Forecast 2017-2022 10.2.2.3 UAE Antivenom Sales Forecast 2017-2022 10.2.2.4 Iran Antivenom Sales Forecast 2017-2022 10.2.3 Africa Market Forecast by Regions (2017-2022) 10.2.3.1 South Africa Antivenom Sales Forecast 2017-2022 10.2.3.2 Nigeria Antivenom Sales Forecast 2017-2022 10.2.3.3 Egypt Antivenom Sales Forecast 2017-2022 10.2.3.4 Algeria Antivenom Sales Forecast 2017-2022 10.3 Antivenom Market Forecast by Type (2017-2022) 10.4 Antivenom Market Forecast by Application (2017-2022) 11 Sales Channel, Distributors, Traders and Dealers 11.1 Sales Channel 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Future Trend 11.2 Distributors, Traders and Dealers 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology 13.2 Analyst Introduction 13.3 Data Source

List of Tables and Figures Figure Antivenom Picture Table Product Specifications of Antivenom Figure EMEA Sales Market Share of Antivenom by Types in 2016 Table Antivenom Types for Major Manufacturers Figure Polyvalent antivenom Picture Figure Monovalent antivenom Picture Table Antivenom Sales Market Share by Applications in 2016 Figure Retail Pharmacies Picture Figure Hospitals Picture Figure Others Picture Figure Germany Antivenom Revenue (Value) and Growth Rate (2012-2022) Figure France Antivenom Revenue (Value) and Growth Rate (2012-2022) Figure UK Antivenom Revenue (Value) and Growth Rate (2012-2022) Figure Italy Antivenom Revenue (Value) and Growth Rate (2012-2022) Figure Russia Antivenom Revenue (Value) and Growth Rate (2012-2022) Figure Turkey Antivenom Revenue (Value) and Growth Rate (2012-2022) Figure Saudi Arabia Antivenom Revenue (Value) and Growth Rate (2012-2022) Figure UAE Antivenom Revenue (Value) and Growth Rate (2012-2022) Figure Israel Antivenom Revenue (Value) and Growth Rate (2012-2022) Figure Iran Antivenom Revenue (Value) and Growth Rate (2012-2022) Figure South Africa Antivenom Revenue (Value) and Growth Rate (2012-2022) Figure Nigeria Antivenom Revenue (Value) and Growth Rate (2012-2022) Figure Egypt Antivenom Revenue (Value) and Growth Rate (2012-2022) Figure Algeria Antivenom Revenue (Value) and Growth Rate (2012-2022) Table CSL Behring Basic Information, Manufacturing Base and Competitors Table CSL Behring Antivenom Type and Applications Table CSL Behring Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors Table Merck & Co., Inc. Antivenom Type and Applications Table Merck & Co., Inc. Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table BTG Plc Basic Information, Manufacturing Base and Competitors Table BTG Plc Antivenom Type and Applications Table BTG Plc Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Antivenom Type and Applications Table Pfizer Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Haffkine Bio-Pharmaceutical Corporation Basic Information, Manufacturing Base and Competitors Table Haffkine Bio-Pharmaceutical Corporation Antivenom Type and Applications Table Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Rare Disease Therapeutics Basic Information, Manufacturing Base and Competitors Table Rare Disease Therapeutics Antivenom Type and Applications Table Rare Disease Therapeutics Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Flynn Pharma Basic Information, Manufacturing Base and Competitors Table Flynn Pharma Antivenom Type and Applications Table Flynn Pharma Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Vins Bioproducts Basic Information, Manufacturing Base and Competitors Table Vins Bioproducts Antivenom Type and Applications Table Vins Bioproducts Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bharat Serums and Vaccines Basic Information, Manufacturing Base and Competitors Table Bharat Serums and Vaccines Antivenom Type and Applications Table Bharat Serums and Vaccines Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Serum Biotech Basic Information, Manufacturing Base and Competitors Table Serum Biotech Antivenom Type and Applications Table Serum Biotech Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table EMEA Antivenom Sales by Manufacturer (2016-2017) Figure EMEA Antivenom Sales Market Share by Manufacturer in 2016 Figure EMEA Antivenom Sales Market Share by Manufacturer in 2017 Table EMEA Antivenom Revenue by Manufacturer (2016-2017) Figure EMEA Antivenom Revenue Market Share by Manufacturer in 2016 Figure EMEA Antivenom Revenue Market Share by Manufacturer in 2017 Table EMEA Antivenom Price by Manufacturer (2016-2017) Figure EMEA Antivenom Sales and Growth (2012-2017) Figure EMEA Antivenom Revenue and Growth (2012-2017) Table EMEA Antivenom Sales by Regions (2012-2017) Table EMEA Antivenom Sales Market Share by Regions (2012-2017) Figure EMEA Antivenom Sales Market Share by Regions in 2012 Figure EMEA Antivenom Sales Market Share by Regions in 2016 Table EMEA Antivenom Revenue by Regions (2012-2017) Table EMEA Antivenom Revenue Market Share by Regions (2012-2017) Figure EMEA Antivenom Revenue Market Share by Regions in 2012 Figure EMEA Antivenom Revenue Market Share by Regions in 2016 Figure Europe Antivenom Sales and Growth (2012-2017) Figure Middle East Antivenom Sales and Growth (2012-2017) Figure Africa Antivenom Sales and Growth (2012-2017) Figure Europe Antivenom Revenue and Growth (2012-2017) Table Europe Antivenom Sales by Countries (2012-2017) Table Europe Antivenom Sales Market Share by Countries (2012-2017) Figure Europe Antivenom Sales Market Share by Countries in 2012 Figure Europe Antivenom Sales Market Share by Countries in 2016 Table Europe Antivenom Revenue by Countries (2012-2017) Table Europe Antivenom Revenue Market Share by Countries (2012-2017) Figure Europe Antivenom Revenue Market Share by Countries in 2012 Figure Europe Antivenom Revenue Market Share by Countries in 2016 Figure Germany Antivenom Sales and Growth (2012-2017) Figure France Antivenom Sales and Growth (2012-2017) Figure UK Antivenom Sales and Growth (2012-2017) Figure Russia Antivenom Sales and Growth (2012-2017) Figure Italy Antivenom Sales and Growth (2012-2017) Figure Turkey Antivenom Sales and Growth (2012-2017) Table Europe Antivenom Sales by Manufacturer (2016-2017) Figure Europe Antivenom Sales Market Share by Manufacturer in 2016 Figure Europe Antivenom Sales Market Share by Manufacturer in 2017 Table Europe Antivenom Revenue by Manufacturer (2016-2017) Figure Europe Antivenom Revenue Market Share by Manufacturer in 2016 Figure Europe Antivenom Revenue Market Share by Manufacturer in 2017 Table Europe Antivenom Sales by Type (2012-2017) Table Europe Antivenom Sales Share by Type (2012-2017) Table Europe Antivenom Sales by Application (2012-2017) Table Europe Antivenom Sales Share by Application (2012-2017) Figure Middle East Antivenom Revenue and Growth (2012-2017) Table Middle East Antivenom Sales by Countries (2012-2017) Table Middle East Antivenom Sales Market Share by Countries (2012-2017) Figure Middle East Antivenom Sales Market Share by Countries in 2012 Figure Middle East Antivenom Sales Market Share by Countries in 2016 Table Middle East Antivenom Revenue by Countries (2012-2017) Table Middle East Antivenom Revenue Market Share by Countries (2012-2017) Figure Middle East Antivenom Revenue Market Share by Countries in 2012 Figure Middle East Antivenom Revenue Market Share by Countries in 2016 Figure Saudi Arabia Antivenom Sales and Growth (2012-2017) Figure Israel Antivenom Sales and Growth (2012-2017) Figure UAE Antivenom Sales and Growth (2012-2017) Figure Iran Antivenom Sales and Growth (2012-2017) Table Middle East Antivenom Sales by Manufacturer (2016-2017) Figure Middle East Antivenom Sales Market Share by Manufacturer in 2016 Figure Middle East Antivenom Sales Market Share by Manufacturer in 2017 Table Middle East Antivenom Revenue by Manufacturer (2016-2017) Figure Middle East Antivenom Revenue Market Share by Manufacturer in 2016 Figure Middle East Antivenom Revenue Market Share by Manufacturer in 2017 Table Middle East Antivenom Sales by Type (2012-2017) Table Middle East Antivenom Sales Share by Type (2012-2017) Table Middle East Antivenom Sales by Application (2012-2017) Table Middle East Antivenom Sales Share by Application (2012-2017) Figure Africa Antivenom Revenue and Growth (2012-2017) Table Africa Antivenom Sales by Countries (2012-2017) Table Africa Antivenom Sales Market Share by Countries (2012-2017) Figure Africa Antivenom Sales Market Share by Countries in 2012 Figure Africa Antivenom Sales Market Share by Countries in 2016 Table Africa Antivenom Revenue by Countries (2012-2017) Table Africa Antivenom Revenue Market Share by Countries (2012-2017) Figure Africa Antivenom Revenue Market Share by Countries in 2012 Figure Africa Antivenom Revenue Market Share by Countries in 2016 Figure South Africa Antivenom Sales and Growth (2012-2017) Figure Nigeria Antivenom Sales and Growth (2012-2017) Figure Egypt Antivenom Sales and Growth (2012-2017) Figure Algeria Antivenom Sales and Growth (2012-2017) Table Middle East Antivenom Sales by Manufacturer (2016-2017) Figure Middle East Antivenom Sales Market Share by Manufacturer in 2016 Figure Middle East Antivenom Sales Market Share by Manufacturer in 2017 Table Middle East Antivenom Revenue by Manufacturer (2016-2017) Figure Middle East Antivenom Revenue Market Share by Manufacturer in 2016 Figure Middle East Antivenom Revenue Market Share by Manufacturer in 2017 Table Middle East Antivenom Sales by Type (2012-2017) Table Middle East Antivenom Sales Share by Type (2012-2017) Table Middle East Antivenom Sales by Application (2012-2017) Table Middle East Antivenom Sales Share by Application (2012-2017) Table EMEA Antivenom Sales by Type (2012-2017) Table EMEA Antivenom Sales Share by Type (2012-2017) Table EMEA Antivenom Revenue by Type (2012-2017) Table EMEA Antivenom Revenue Share by Type (2012-2017) Figure EMEA Polyvalent antivenom Sales Growth (2012-2017) Figure EMEA Polyvalent antivenom Price (2012-2017) Figure EMEA Monovalent antivenom Sales Growth (2012-2017) Figure EMEA Monovalent antivenom Price (2012-2017) Table EMEA Antivenom Sales by Application (2012-2017) Table EMEA Antivenom Sales Share by Application (2012-2017) Figure EMEA Retail Pharmacies Sales Growth (2012-2017) Figure EMEA Hospitals Sales Growth (2012-2017) Figure EMEA Others Sales Growth (2012-2017) Figure EMEA Antivenom Sales, Revenue and Growth Rate (2017-2022) Table EMEA Antivenom Sales Forecast by Regions (2017-2022) Table EMEA Antivenom Market Share Forecast by Regions (2017-2022) Table Europe Antivenom Sales Forecast by Regions (2017-2022) Figure Germany Antivenom Sales Forecast 2017-2022 Figure France Antivenom Sales Forecast 2017-2022 Figure UK Antivenom Sales Forecast 2017-2022 Figure Russia Antivenom Sales Forecast 2017-2022 Figure Italy Antivenom Sales Forecast 2017-2022 Figure Turkey Antivenom Sales Forecast 2017-2022 Table Middle East Sales Forecast by Regions (2017-2022) Figure Saudi Arabia Antivenom Sales Forecast 2017-2022 Figure Israel Antivenom Sales Forecast 2017-2022 Figure UAE Antivenom Sales Forecast 2017-2022 Figure Iran Antivenom Sales Forecast 2017-2022 Table Africa Sales Forecast by Regions (2017-2022) Figure South Africa Antivenom Sales Forecast 2017-2022 Figure Nigeria Antivenom Sales Forecast 2017-2022 Figure Egypt Antivenom Sales Forecast 2017-2022 Figure Algeria Antivenom Sales Forecast 2017-2022 Table EMEA Antivenom Sales Forecast by Type (2017-2022) Table EMEA Antivenom Market Share Forecast by Type (2017-2022) Table EMEA Antivenom Sales Forecast by Application (2017-2022) Table EMEA Antivenom Market Share Forecast by Application (2017-2022) Table Distributors/Traders/ Dealers List